Multi-Dose Nasal Delivery
Spravato Nasal Spray
Janssen selected an Aptar technology as the preferred drug delivery device for their Esketamine product, used to treat severe depression. The project team identified a need to customise the baseline device and saw Shore as the perfect partner to lead this aspect of the program.
Showcasing the strengths of our combined design and engineering team, this project saw us successfully develop a version of the platform drug delivery device to meet the user group’s needs and our customer’s commercial launch objectives. Included in our scope was the development of commercial Instructions for Use (IFU) and secondary packaging to complement the improved device design.
Our innovative solution enhances the device’s usability while ensuring no impact on the core functional elements of the platform technology.
- Platform device customised to customer and patient needs
- Improved reliability and performance in users hands
- Enhanced user interface
- Complimentary packaging and IFU solutions
- Valuable intellectual property generated for Janssen
Design for Manufacture (DFM)
Prototype & Evaluation
New Product Integration